Published: Apr 2014
ACE Report #6213
Ace Report Cover General Orthopaedics

WCO-IOF: Rituximab for rheumatoid arthritis positively impacts BMD of femoral neck

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

The effect of rituximab therapy on bone mineral density with rheumatoid arthritis patients

Contributing Authors: MV Koroleva TA Raskina

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.